TPE, a procedure that utilizes an apheresis machine to remove and replace a patient's plasma, will target harmful substances—such as autoantibodies, immune complexes, and toxins—in the bloodstream, ...
CHICAGO, April 12, 2024 /PRNewswire/ -- Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from ...
A new study has identified a blood-cleansing procedure known as therapeutic apheresis as a potential game-changer in kidney transplant management, raising fresh hope for patients facing transplant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results